Ask Warren

L&C Bio

290650 · KOSDAQ · ₩290650 · 엘앤씨바이오

₩24,950▲ ₩1,150 (4.83%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Ex-Rights (Bonus Issue)권리락 (무상증자)

    Predicted impact: Medium

    Ex-rights date for a bonus share issue; size unknown, mechanical price adjustment, no value change.

    Oct 23, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)

    Predicted impact: Low

    Result report for the already-announced ₩144.7B rights offering, about 8% of market value.

    Oct 22, 2026Open on DART
  • Securities Issuance Results Report증권발행실적보고서

    Predicted impact: Low

    Oct 22, 2026Open on DART
  • Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)

    Predicted impact: Medium· Actual: −0.7% vs sector, volume 1.6× normal (5 trading days)

    Rights offering results follow earlier amended prospectus and share issue filings already covering the same new-share offering.

    Oct 16, 2026Open on DART
  • Final Determination of Issue Price for Rights Offering유상증자최종발행가액확정

    Predicted impact: Low· Actual: +10.5% vs sector, volume 3.1× normal (5 trading days)

    Final rights offering price set; terms and size already reported in last 14 days.

    Oct 12, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서

    Predicted impact: Low· Actual: +10.5% vs sector, volume 3.1× normal (5 trading days)

    Oct 12, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)

    Predicted impact: Medium· Actual: +10.5% vs sector, volume 3.1× normal (5 trading days)

    Terms set for equity registration tied to bonus share issue; large market value, size not stated.

    Oct 12, 2026Open on DART
  • Amended: Bonus share issue decision[기재정정]주요사항보고서(유무상증자결정)

    Predicted impact: Low· Actual: +10.5% vs sector, volume 3.1× normal (5 trading days)

    Oct 12, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 30, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 23, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 18, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 18, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Sep 10, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 9, 2026Open on DART
  • Ex-Rights Date (Rights Offering)권리락 (유상증자)Sep 2, 2026Open on DART
  • Determination of Issue Price for First Tranche of Rights Offering유상증자1차발행가액결정Sep 2, 2026Open on DART
  • Prospectus투자설명서Sep 2, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Sep 2, 2026Open on DART
  • Amended: Bonus share issue decision[기재정정]주요사항보고서(유무상증자결정)Sep 2, 2026Open on DART
  • Securities registration statement효력발생안내( 2026.8.18. 제출 증권신고서(지분증권) )Sep 2, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Aug 31, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Aug 18, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 12, 2026Open on DART
  • Occurrence of Derivatives Trading Loss파생상품거래손실발생Aug 11, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Aug 11, 2026Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Aug 11, 2026Open on DART
  • Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Aug 11, 2026Open on DART
  • Securities registration statement증권신고서(지분증권)Aug 3, 2026Open on DART
  • Trading halt주권매매거래정지 (무상증자)Jul 31, 2026Open on DART
  • Bonus share issue decision주요사항보고서(유무상증자결정)Jul 31, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 23, 2026Open on DART
  • Amended: Audit report submitted[기재정정]감사보고서제출Jun 12, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Jun 10, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 5, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Jun 5, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고May 29, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)May 11, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)May 11, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 30, 2026Open on DART
  • Exercise of Conversion Rights전환청구권행사Apr 23, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 16, 2026Open on DART
  • Corporate value-up plan기업가치제고계획(자율공시)Apr 1, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: L&C Bio / 엘앤씨바이오 / 290650 / KRX:290650

Source: KRX statistical information